<unk>  is a derivative of<unk>  that is FDA approved for the treatment of moderate to severe dry eye syndromes, including keratoconjunctivitis sicca.<unk>  is indicated especially in patients who remain symptomatic after an adequate trial of therapy with artificial tear solutions..   Common adverse reactions include transient blurring of vision , ocular discomfort or irritation, matting or stickiness of eyelashes
Photophobia, hypersensitivity, edema of the eyelids and hyperemia.
Hydroxypropyl cellulose
Carboxymethyl cellulose
Gitoformate
Calcium alginate
Cornstarch
Chondroitin sulfate
Polydimethylsiloxane
Polyvinyl chloride